Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms

Projected increase in total knee arthroplasty in the United States – an alternative projection model

(2017) M.C.S. Inacio et al.   OSTEOARTHRITIS AND CARTILAGE

Mechanisms and consequences of bacterial resistance to antimicrobial peptides

(2016) D.I. Andersson et al.   DRUG RESISTANCE UPDATES

Risk of Reinfection After Treatment of Infected Total Knee Arthroplasty

(2016) Adam R. Cochran et al.   JOURNAL OF ARTHROPLASTY

Vancomycin displays time-dependent eradication of matureStaphylococcus aureusbiofilms

(2016) Virginia Post et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus

(2016) Mohamed F. Mohamed et al.   Scientific Reports

The incidence of late prosthetic joint infections

(2015) Kaisa Huotari et al.   Acta Orthopaedica

LL-37-induced host cell cytotoxicity depends on cellular expression of the globular C1q receptor (p33)

(2015) D. Svensson et al.   BIOCHEMICAL JOURNAL

Mechanisms of biofilm inhibition and degradation by antimicrobial peptides

(2015) L. Segev-Zarko et al.   BIOCHEMICAL JOURNAL

Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship

(2015) Marcelo B.P. Siqueira et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Anti-Staphylococcal Biofilm Effects of Human Cathelicidin Peptides

(2015) Biswajit Mishra et al.   ACS Medicinal Chemistry Letters

The role of microbial biofilms in prosthetic joint infections

(2014) Herbert O Gbejuade et al.   Acta Orthopaedica

Staphylococcus aureuschronic and relapsing infections: Evidence of a role for persister cells

(2014) Brian P. Conlon   BIOESSAYS

Differential responses of osteoblasts and macrophages upon Staphylococcus aureus infection

(2014) Therwa Hamza et al.   BMC MICROBIOLOGY

Prosthetic Joint Infection

(2014) A. J. Tande et al.   CLINICAL MICROBIOLOGY REVIEWS

Biofilms in periprosthetic orthopedic infections

(2014) Stephen J McConoughey et al.   Future Microbiology

Reduced Vancomycin Susceptibility in anIn VitroCatheter-Related Biofilm Model Correlates with Poor Therapeutic Outcomes in Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

(2013) Wessam Abdelhady et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Anti-biofilm activity of silver nanoparticles against different microorganisms

(2013) Fidel Martinez-Gutierrez et al.   BIOFOULING

Current management of prosthetic joint infections in adults: results of an Emerging Infections Network survey

(2013) Jonas Marschall et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

The Antimicrobial Peptide LL-37 Alters Human Osteoblast Ca2+Handling and Induces Ca2+-Independent Apoptosis

(2013) Johanna Säll et al.   Journal of Innate Immunity

Mechanisms and Fitness Costs of Resistance to Antimicrobial Peptides LL-37, CNY100HL and Wheat Germ Histones

(2013) Hava Lofton et al.   PLoS One

Human Host Defense Peptide LL-37 Stimulates Virulence Factor Production and Adaptive Resistance in Pseudomonas aeruginosa

(2013) Nikola Strempel et al.   PLoS One

Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides

(2013) Letícia S. Tavares et al.   Frontiers in Microbiology

Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus

(2012) Jabeen Noore et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A comprehensive summary of LL-37, the factotum human cathelicidin peptide

(2012) Dieter Vandamme et al.   CELLULAR IMMUNOLOGY

Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America

(2012) D. R. Osmon et al.   CLINICAL INFECTIOUS DISEASES

Choice and Doses of Antibacterial Agents for Cement Spacers in Treatment of Prosthetic Joint Infections: Review of Published Studies

(2012) D. Iarikov et al.   CLINICAL INFECTIOUS DISEASES

Antibacterial activity of the human host defence peptide LL-37 and selected synthetic cationic lipids against bacteria associated with oral and upper respiratory tract infections

(2012) K. Leszczynska et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Economic Burden of Periprosthetic Joint Infection in the United States

(2012) Steven M. Kurtz et al.   JOURNAL OF ARTHROPLASTY

Natural and synthetic cathelicidin peptides with anti-microbial and anti-biofilm activity against Staphylococcus aureus

(2011) Scott N Dean et al.   BMC MICROBIOLOGY

A novel protocol for the production of recombinant LL-37 expressed as a thioredoxin fusion protein

(2011) Yifeng Li   PROTEIN EXPRESSION AND PURIFICATION

Effects of an LL-37-Derived Antimicrobial Peptide in an Animal Model of Biofilm Pseudomonas Sinusitis

(2009) Sri Kiran Chennupati et al.   American Journal of Rhinology & Allergy

Prosthetic Joint Infection Risk after TKA in the Medicare Population

(2009) Steven M. Kurtz et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Prosthetic Joint Infection Risk After Total Hip Arthroplasty in the Medicare Population

(2009) Kevin L. Ong et al.   JOURNAL OF ARTHROPLASTY

Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis

(2009) J S Cargill et al.   JOURNAL OF CLINICAL PATHOLOGY

The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic Leukocytes

(2008) A. Bjorstad et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Silver nanoparticles as a new generation of antimicrobials

(2008) Mahendra Rai et al.   BIOTECHNOLOGY ADVANCES

Periprosthetic Joint Infection: The Incidence, Timing, and Predisposing Factors

(2008) Luis Pulido et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation

(2008) J. Overhage et al.   INFECTION AND IMMUNITY